🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

New in Perspectives: Essay: Landscape of subsequent therapies in perioperative #immunotherapy trials across multiple #cancer types thelancet.com/journals/lanon…

Excited to share our work at #AACR #liquidbiopsy. Amazing science presented at the conference. #SanDiego Karl Semaan, MD, MSc Srinivas Viswanathan Toni Choueiri, MD Sylvan Baca MD PhD (Hiring!)

Kidney Paper 4 Our very own Talal El Zarif, MD and Karl Semaan, MD, MSc described the epigenetic landscape of sarcomatoid #RCC, identifying transcriptional programs associated with patient outcomes and response to immunotherapy. They have also established a blood-based diagnostic approach using

1/ 🧵Excited to share our latest study published in Nature Cancer co-led with amazing co-first authors and friends Tejas Jammihal and Chris Labaki under the exceptional mentorship of Toni Choueiri, MD David Braun Sachet Ashok Shukla nature.com/articles/s4301…

High-purity CTC RNA sequencing identifies prostate cancer lineage phenotypes prognostic for clinical outcomes aacrjournals.org/cancerdiscover… Study investigates treatment resistance in metastatic #ProstateCancer , often driven by androgen receptor (AR) alterations and lineage

Tour de force presentation on HIF2A expression and clinical outcomes in ccRCC and sarc-Rcc by Dana-Farber Lank Center for Genitourinary Oncology superstar Rashad Nawfal, MD! Sylvan Baca MD PhD (Hiring!) Dana-Farber #FreedmanLab

Excellent presentation from the #IMDC superstar lead fellow Razane El Hajj Chehade #RHC assessing low vs low-intermediate substrata of IMDC risk groups! Daniel Heng Sylvan Baca MD PhD (Hiring!) Dana-Farber

So proud of mentees Razane El Hajj Chehade, Karl Semaan, MD, MSc, Rashad Nawfal, MD, and Marc Eid for their fantastic talks at ASCO #GU25. Their translational projects should lead to better outcomes for patients with kidney or prostate cancer.

⭐️Future of GU oncology is VERY bright. LOVED learning about the cutting edge research of the Fellows and trainees at OncLive.com GU Fellows forum at #GU25. Also really enjoyed joining global GU leaders and superb mentors Dr. Choueiri Dr. McKay and Dr. Garcia as they provided

I am absolutely thrilled to have matched at Brigham and Women's Medicine Residents Brigham and Women's Hospital for internal medicine residency! Incredibly grateful to my amazing mentors, colleagues, and friends who have supported me throughout this journey Sylvan Baca MD PhD (Hiring!) #MattFreedman Toni Choueiri, MD #Match2025

Thank you AACR for the Waun Ki Hong Award! My talk will be addressing Precision Medicine in Renal Cell Carcinoma. See you in Chicago! cc: Dana-Farber

If you are at #AACR25 and interested in #pancreaticcancer and #liquidbiopsy, check out our poster #5926 section 32 from 2-5pm today.

At #AACR25, Dana-Farber researchers present a non-invasive method to distinguish classical vs. basal #PDAC using circulating tumor epigenomic profiles which could pave the way for more personalized treatment decisions. #PancreaticCancer #CancerResearch Karl Semaan, MD, MSc Marc Eid

Toni Choueiri, MD with an overview of advances in the field of kidney cancer #RCC leading to clinically meaningful progress with adjuvant therapy and personalized vaccines #BioBeirut Lebanese University

Pre-#ASCO25 appreciation tweet to Toni Choueiri, MD and David Braun who are always taking the time to meet and discuss projects/presentations despite very busy schedules! Looking forward to a reunion in Chicago! OncoAlert

Hello #MedX! I’m Denise Mourad, PGY-3 IM resident Central Michigan U.. Excited to apply for #CardiologyFellowship #CardioMatch #WomenInCardiology #Match2026! My work focuses on education, research, mentorship, and leadership. Looking forward to connecting with programs and peers!